David H. Li - 07 Apr 2026 Form 4 Insider Report for Ingevity Corp (NGVT)

Reporting relationship: President & CEO, Director
Issuer ticker: NGVT
Reported as of: 07 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Apr 2026, 17:30:13 UTC
Prior SEC filing: 06 Apr 2026
Next SEC filing: 08 May 2026
Source filing: View source filing
Reporting owner signature: David H. Li By: Mavis G. Huger as Attorney-in-Fact

Key filing fact

David H. Li filed Form 4 for Ingevity Corp (NGVT) on 09 Apr 2026.

Key facts

This page summarizes David H. Li's Form 4 filing for Ingevity Corp (NGVT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 09 Apr 2026, 17:30.

Change

Previous filing in this sequence was filed on 06 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001436880 Primary reporting owner

Li David H

Relationship: President & CEO, Director
Address: C/O INGEVITY CORPORATION, 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON
Signature: David H. Li By: Mavis G. Huger as Attorney-in-Fact
Signature date: 09 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NGVT transaction

Common Stock

Tax liability

Transaction value
Shares: -13,102
Change %: -8.3%
Price: $70.57^*
Shares after: 144,210
Date: 07 Apr 2026
Ownership: Direct
Footnotes: F1

NGVT transaction

Common Stock

Tax liability

Transaction value
Shares: -3,574
Change %: -2.5%
Price: $70.57^*
Shares after: 140,636
Date: 07 Apr 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 422 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP"), for the purchase period of January 1, 2026 to March 31, 2026. In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2025.